#BEGIN_DRUGCARD DB04553

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
600-18-0

# ChEBI_ID:
30831

# Chemical_Formula:
C4H6O3

# Chemical_IUPAC_Name:
2-oxobutanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2-Oxobutanoic Acid

# HET_ID:
2KT

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C4H6O3/c1-2-3(5)4(6)7/h2H2,1H3,(H,6,7)

# InChI_Key:
InChIKey=TYEYBOSBBBHJIV-UHFFFAOYSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00109

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
4553

# Mechanism_Of_Action:
Not Available

# Melting_Point:
33 Â°C

# Molecular_Weight_Avg:
102.0886

# Molecular_Weight_Mono:
102.031694058

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1TZK

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.07

# Predicted_LogS:
-0.11

# Predicted_Water_Solubility:
7.92e+01 g/l

# Primary_Accession_No:
DB04553

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
58

# PubChem_Substance_ID:
46504977

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT00126

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCC(=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:23:27 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AJ606310

# Drug_Target_1_GenBank_ID_Protein:
38304072

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>1560 bp
ATGAGTCCGCGAGAAATTGAGGTTTCCGAGCCGCGCGAGGTTGGTATCACCGAGCTCGTG
CTGCGCGATGCCCATCAGAGCCTGATGGCCACACGAATGGCAATGGAAGACATGGTCGGC
GCCTGTGCAGACATTGATGCTGCCGGGTACTGGTCAGTGGAGTGTTGGGGTGGTGCCACG
TATGACTCGTGTATCCGCTTCCTCAACGAGGATCCTTGGGAGCGTCTGCGCACGTTCCGC
AAGCTGATGCCCAACAGCCGTCTCCAGATGCTGCTGCGTGGCCAGAACCTGCTGGGTTAC
CGCCACTACAACGACGAGGTCGTCGATCGTTTCGTCGACAAGTCCGCTGAGAACGGCATG
GACGTGTTCCGTGTCTTCGACGCCATGAATGATCCCCGCAATATGGCGCACGCCATGGCT
GCCGTCAAGAAGGCCGGCAAGCACGCGCAGGGCACCATTTGCTACACGATCAGCCCGGTC
CACACCGTTGAGGGCTATGTCAAGCTTGCTGGTCAGCTGCTCGACATGGGTGCTGATTCC
ATCGCCCTGAAGGACATGGCCGCCCTGCTCAAGCCGCAGCCGGCCTACGACATCATCAAG
GCCATCAAGGACATACGGCCAGAAGACGCAGATCAACCTGCACTGCACTCCACCACGGGT
GTCACCGAGGTCTCCCTCATGAAGGCCATCGAGGCCGGCGTCGACACCGCCATCTCGTCC
ATGTCGCTCGGCCCGGGCCACAACCCCACCGAGTCGGTTGCCGAGATGCTCGAGGGCACC
GGGTACACCACCAACCTTGACTACGATCGCCTGCACAAGATCCGCGATCACTTCAAGGCC
ATCCGCCCGAAGTACAAGAAGTTCGAGTCGAAGACGCTTGTCGACACCTCGATCTTCAAG
TCGCAGATCCCCGGCGGCATGCTGTCCAACATGGAGTCGCAGCTGCGCGCCCAGGGCGCC
GAGGACAAGATGGACGAGGTCATGGCAGAGGTGCCGCGCGTCCGAAGGCCGGCGCCGGTT
TTCCCCGCCCCTGGTCACCCCGTCCAGCCAGATCGTCGGCACGCAGGCCTGTTCAACGTG
ATGATGGGCGAGTACAAGAGGATGACCGGCGAGTTCGCAGATATCATGCTCGGCTACTAC
GGCGCCACGCCGGCCGATCGCGATCCGAAGTGGTCAGTTGGCGAGGAGCATCGCAGAGCG
ATCACCCAGCGCCCGGCCGATCACGATCCGAAGGTGGTCAAGTTGGCCGAGGAGCAGTCC
GGCAAGAAGCCGATCACCCAGCGCCCGGCCGATCTGCTGCCCCCCGAGTGGGAGGAGCAG
TCCAAGGAGCCGCGCCCTAAGGGCTTCAACGGCACCGACGAGGACGTGCTCACCTATGCA
CTGTTCCCGCAGGTCGCTCCGGTCTTCTTCGAGAGTCGGCCGAGGGCCGCAGAGGTGGCT
CTCACCGATGCCCAGCTGAAGGCCGAGGCGAGGGCGACGAGAAGTGTCGCCGTGGCCGGT
CCCGTCACCTACAACGTGAACGTGCGGAACCGTCCGCAAGTCACCGTTCAGCAGGCGTGA

# Drug_Target_1_General_Function:
Energy production and conversion

# Drug_Target_1_General_References:
8365490	Thornton CG, Kumar GK, Shenoy BC, Haase FC, Phillips NF, Park VM, Magner WJ, Hejlik DP, Wood HG, Samols D: Primary structure of the 5 S subunit of transcarboxylase as deduced from the genomic DNA sequence. FEBS Lett. 1993 Sep 13;330(2):191-6.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2983

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
55650

# Drug_Target_1_Name:
Methylmalonyl-CoA carboxyltransferase 5S subunit

# Drug_Target_1_Number_of_Residues:
505

# Drug_Target_1_PDB_ID:
1RQE

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00682	HMGL-like
PF02436	PYC_OADA

# Drug_Target_1_Protein_Sequence:
>Methylmalonyl-CoA carboxyltransferase 5S subunit
MSPREIEVSEPREVGITELVLRDAHQSLMATRMAMEDMVGACADIDAAGYWSVECWGGAT
YDSCIRFLNEDPWERLRTFRKLMPNSRLQMLLRGQNLLGYRHYNDEVVDRFVDKSAENGM
DVFRVFDAMNDPRNMAHAMAAVKKAGKHAQGTICYTISPVHTVEGYVKLAGQLLDMGADS
IALKDMAALLKPQPAYDIIKAIKDTYGQKTQINLHCHSTTGVTEVSLMKAIEAGVDVVDT
AISSMSLGPGHNPTESVAEMLEGTGYTTNLDYDRLHKIRDHFKAIRPKYKKFESKTLVDT
SIFKSQIPGGMLSNMESQLRAQGAEDKMDEVMAEVPRVRKAAGFPPLVTPSSQIVGTQAV
FNVMMGEYKRMTGEFADIMLGYYGASPADRDPKVVKLAEEQSGKKPITQRPADLLPPEWE
KQSKEAATLKGFNGTDEDVLTYALFPQVAPVFFEHRAEGPHSVALTDAQLKAEAEGDEKS
LAVAGPVTYNVNVGGTVREVTVQQA

# Drug_Target_1_Reaction:
(S)-methylmalonyl-CoA + pyruvate = propanoyl-CoA + oxaloacetate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
The 5S subunit specifically catalyzes the transfer of the carboxyl group from biotin of the 1.3S subunit to pyruvate to form oxaloacetate and 1.3S biotin

# Drug_Target_1_SwissProt_ID:
Q70AC7

# Drug_Target_1_SwissProt_Name:
5S_PROFR

# Drug_Target_1_Synonyms:
EC 2.1.3.1
Transcarboxylase 5S subunit

# Drug_Target_1_Theoretical_pI:
5.51

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasmic

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
M73488

# Drug_Target_2_GenBank_ID_Protein:
150963

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
acdS

# Drug_Target_2_Gene_Sequence:
>1017 bp
ATGAACCTGCAACGATTCCCTCGTTACCCGCTGACTTTCGGGCCGACGCCAATCCAACCG
CTAGCGCGTCTGAGCAAGCACCTCGGCGGCAAAGTGCATCTGTATGCGAAACGCGAAGAC
TGCAACAGCGGCCTGGCGTTCGGTGGCAACAAGACACGCAAGCTCGAATATCTGATCCCT
GAAGCGCTTGCTCAGGGTTGCGACACGCTCGTGTCGATCGGCGGCATTCAGTCGAACCAG
ACGCGCCAGGTGGCGGCCGTGGCGGCTCATCTGGGCATGAAGTGCGTGCTGGTGCAGGAG
AACTGGGTCAACTATTCGGACGCAGTCTACGACCGCGTCGGCAACATCCAGATGTCGCGC
ATTCTCGGCGCCGATGTTCGCCTCGTGCCCGACGGCTTCGACATCGGTTTTCGCAGGAGC
TGGGAGGATGCGCTGGAAAGCGTGCGGGCGGCCGGCGGCAAGCCGTATGCGATTCCGGCA
GGCTGCTCGGATCACCCGCTCGGCGGCCTGGGTTTCGTCGGCTTCGCGGAGGAGGTGCGG
GCGCAGGAAGCCGAATTGGGCTTCAAATTCGACTATGTCGTCGTGTGTTCCGTGACCGGC
AGCACGCAGGCCGGCATGGTGGTGGGCTTCGCCGCTGACGGCCGCGCCGATCGCGTGATC
GGCGTCGACGCTTCGGCCAAACCCGCGCAGACGCGCGAGCAGATCACCCGCATCGCGAGA
CAGACCGCGGAGAAAGTCGGCCTGGAGCGCGATATCATGCGGGCCGACGTGGTGCTCGAC
GAGCGCTTCGCGGGTCCGGAATACGGATTGCCGAACGAAGGCACGCTGGAAGCGATCCGC
TTGTGCGCGCGCACGGAGGGCATGCTGACCGATCCCGTCTACGAAGGCAAATCGATGCAC
GGCATGATCGAAATGGTGCGCAACGGCGAATTTCCGGAAGGCTCGCGCGTGCTGTATGCG
CACCTCGGCGGGGTGCCGGCGTTGAACGGCTACAGCTTTATCTTCCGAGACGGCTGA

# Drug_Target_2_General_Function:
Amino acid transport and metabolism

# Drug_Target_2_General_References:
1885510	Sheehy RE, Honma M, Yamada M, Sasaki T, Martineau B, Hiatt WR: Isolation, sequence, and expression in Escherichia coli of the Pseudomonas sp. strain ACP gene encoding 1-aminocyclopropane-1-carboxylate deaminase. J Bacteriol. 1991 Sep;173(17):5260-5.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2518

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
36672

# Drug_Target_2_Name:
1-aminocyclopropane-1-carboxylate deaminase

# Drug_Target_2_Number_of_Residues:
338

# Drug_Target_2_PDB_ID:
1RQX

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00291	PALP

# Drug_Target_2_Protein_Sequence:
>1-aminocyclopropane-1-carboxylate deaminase
MNLQRFPRYPLTFGPTPIQPLARLSKHLGGKVHLYAKREDCNSGLAFGGNKTRKLEYLIP
EALAQGCDTLVSIGGIQSNQTRQVAAVAAHLGMKCVLVQENWVNYSDAVYDRVGNIQMSR
ILGADVRLVPDGFDIGFRRSWEDALESVRAAGGKPYAIPAGCSDHPLGGLGFVGFAEEVR
AQEAELGFKFDYVVVCSVTGSTQAGMVVGFAADGRADRVIGVDASAKPAQTREQITRIAR
QTAEKVGLERDIMRADVVLDERFAGPEYGLPNEGTLEAIRLCARTEGMLTDPVYEGKSMH
GMIEMVRNGEFPEGSRVLYAHLGGVPALNGYSFIFRDG

# Drug_Target_2_Reaction:
1-aminocyclopropane-1-carboxylate + H2O = 2-oxobutanoate + NH3

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Catalyzes a cyclopropane ring-opening reaction, the irreversible conversion of 1-aminocyclopropane-1-carboxylate (ACC) to ammonia and alpha-ketobutyrate. Allows growth on ACC as a nitrogen source

# Drug_Target_2_SwissProt_ID:
Q00740

# Drug_Target_2_SwissProt_Name:
1A1D_PSEUD

# Drug_Target_2_Synonyms:
ACC deaminase
ACCD
EC 3.5.99.7

# Drug_Target_2_Theoretical_pI:
6.52

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB04553
